Predictive value of triglyceride/glucose index for cardiac outcomes in non-diabetic renal transplant recipients

References

• Baigent C, Burbury K, Wheeler D. Premature cardiovascular disease in chronic renal failure. Lancet. 2000;356(9224):147–152. doi: 10.1016/S0140-6736(00)02456-9.
   PubMed Web of Science ®Google Scholar
• Kidney Disease: ımproving Global Outcomes (KDIGO) Transplant Work Group. KDIGO clinical practice guideline for the care of kidney transplant recipients. Am J Transplant. 2009;9:1–155.
   PubMed Web of Science ®Google Scholar
• Methven S, Steenkamp R, Fraser S. UK renal registry 19th annual report: chapter 5 survival and causes of death in UK adult patients on renal replacement therapy in 2015: national and Centre-specific analyses. Nephron. 2017;137 Suppl 1(1):117–150. doi: 10.1159/000481367.
   PubMedGoogle Scholar
• DeFronzo RA. From the triumvirate to the ominous octet: a new paradigm for the treatment of type 2 diabetes mellitus. Diabetes. 2009;58(4):773–795. doi: 10.2337/db09-9028.
   PubMed Web of Science ®Google Scholar
• Mills JD, Grant PJ. Insulin resistance, hemostatic factors, and cardiovascular risk. Diabetes & Vascular Disease. 2002;2(1):19–26. doi: 10.1177/14746514020020011301.
   Google Scholar
• Rutter MK, Meigs JB, Sullivan LM, et al. Insulin resistance, the metabolic syndrome, and incident cardiovascular events in the framingham offspring study. Diabetes. 2005;54(11):3252–3257. doi: 10.2337/diabetes.54.11.3252.
   PubMed Web of Science ®Google Scholar
• Le W, Cong H, Zhang J, et al. Triglyceride-glucose index predicts adverse cardiovascular events in patients with diabetes and acute coronary syndrome. Cardiovasc Diabetol. 2020;19(1):80. doi: 10.1186/s12933-020-01054-z.
   PubMed Web of Science ®Google Scholar
• DeFronzo RA, Tobin JD, Andres R. Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol. 1979;237(3):E214–223.
   PubMed Web of Science ®Google Scholar
• Du T, Yuan G, Zhang M, et al. Clinical usefulness of lipid ratios, visceral adiposity indicators, and the triglycerides and glucose index as risk markers of insulin resistance. Cardiovasc Diabetol. 2014;13(1):146. doi: 10.1186/s12933-014-0146-3.
   PubMed Web of Science ®Google Scholar
• Guerrero RF, Simental LE. González M,abundis EM,zavala MG,gonzalez SO,camarena OJ,moran MR.The product of triglycerides and glucose, is a simple measure of insulin sensitivity. Comparison with the euglycemic-hyperinsulinemic clamp. J Clin Endocrinol Metab. 2010;95:3347–3351.
   PubMed Web of Science ®Google Scholar
• Unger G, Benozzi SF, Perruzza F, et al. Triglycerides and glucose index: a useful indicator of insulin resistance. Endocrinol Nutr. 2014;61(10):533–540. doi: 10.1016/j.endonu.2014.06.009.
   PubMedGoogle Scholar
• Da Silva A, Caldas AP, Hermsdorf HM, et al. Triglyceride-glucose index is associated with symptomatic coronary artery disease in patients in secondary care. Cardiovasc Diabetol. 2019;18(1):89. doi: 10.1186/s12933-019-0893-2.
   PubMed Web of Science ®Google Scholar
• Lambrinoudaki I, Kazani MV, Armeni E, et al. The TyG index as a marker of subclinical atherosclerosis and arterial stiffness in lean and overweight postmenopausal women. Heart Lung Circ. 2018;27(6):716–724. doi: 10.1016/j.hlc.2017.05.142.
   PubMed Web of Science ®Google Scholar
• Park K, Ahn CW, Lee SB, et al. Elevated TyG index predicts the progression of coronary artery calcification. Diabetes Care. 2019;42(8):1569–1573. doi: 10.2337/dc18-1920.
   PubMed Web of Science ®Google Scholar
• Laakso M, Kuusisto J. Insulin resistance and hyperglycemia in cardiovascular disease development. Nat Rev Endocrinol. 2014;10(5):293–302. doi: 10.1038/nrendo.2014.29.
   PubMed Web of Science ®Google Scholar
• Nishimura M, Tokoro T, Nishida M, et al. Association of ınsulin resistance with de novo coronary stenosis after percutaneous coronary artery ıntervention in hemodialysis patients. Nephron Clin Pract. 2008;109(1):c9–17. doi: 10.1159/000132391.
   PubMedGoogle Scholar
• Uetani T, Amano T, Harada K, et al. Impact of insulin resistance on post-procedural myocardial injury and clinical outcomes in patients who underwent elective coronary interventions with drug-eluting stents. JACC Cardiovasc Interv. 2012;5(11):1159–1167. doi: 10.1016/j.jcin.2012.07.008.
   PubMed Web of Science ®Google Scholar
• Won KB, Park EJ, Han D, et al. Triglyceride glucose index is an independent predictor for the progression of coronary artery calcification in the absence of heavy coronary artery calcification at baseline. Cardiovasc Diabetol. 2020;19(1):34. doi: 10.1186/s12933-020-01008-5.
   PubMed Web of Science ®Google Scholar
• Shang J, Yu D, Cai Y, et al. The triglyceride glucose index can predict newly diagnosed biopsy-proven diabetic nephropathy in type 2 diabetes: a nested case-control study. Medicine (Baltimore). 2019;98(46):e17995. doi: 10.1097/MD.0000000000017995.
   PubMed Web of Science ®Google Scholar
• Chiu H, Tsai HJ, Huang JC, et al. Associations between the triglyceride-glucose index and micro-and macro-angiopathies in type 2 diabetes mellitus. Nutrients. 2020;12(2):328. doi: 10.3390/nu12020328.
   PubMed Web of Science ®Google Scholar
• De Vries AP, Bakker S, Van Son WJ, et al. Insulin resistance as putative cause of chronic renal transplant dysfunction. Am J Kidney Dis. 2003;41(4):859–867. doi: 10.1016/s0272-6386(03)00034-9.
   PubMed Web of Science ®Google Scholar
• Levey AS, Beto JA, Coronado BE, et al. Controlling the epidemic of cardiovascular disease in chronic renal disease: what do we know? What do we need to learn? Where do we go from here? National kidney foundation task force on cardiovascular disease. Am J Kidney Dis. 1998;32(5):853–906. doi: 10.1016/s0272-6386(98)70145-3.
   PubMed Web of Science ®Google Scholar
• First MR, Neylan JF, Rocher LL, et al. Hypertension after renal transplantation. J Am Soc Nephrol. 1994;4:30–36.
   PubMed Web of Science ®Google Scholar
• Kasiske BL, Klinger D. Cigarette smoking in renal transplant recipients. J Am Soc Nephrol. 2000;11(4):753–759. doi: 10.1681/ASN.V114753.
   PubMed Web of Science ®Google Scholar
• Friedman AN, Miskulin DC, Rosenberg IH, et al. Demographics and trends in overweight and obesity in patients at the time of kidney transplantation. Am J Kidney Dis. 2003;41(2):480–487. doi: 10.1053/ajkd.2003.50059.
   PubMed Web of Science ®Google Scholar
• Parikh CR, Klem P, Wong C, et al. Obesity as an independent predictor of posttransplant diabetes mellitus. Transplant Proc. 2003;35(8):2922–2926. doi: 10.1016/j.transproceed.2003.10.074.
   PubMed Web of Science ®Google Scholar
• De Vries AP, Bakker S, Van Son WJ, et al. Metabolic syndrome is associated with impaired long-term renal allograft function: not all component criteria contribute equally. Am J Transplant. 2004;4(10):1675–1683. doi: 10.1111/j.1600-6143.2004.00558.x.
   PubMed Web of Science ®Google Scholar
• Sheu A, Depczynski B, O'Sullivan J, et al. The effect of different glycaemic states on renal transplant outcomes. J Diabetes Res. 2016;2016:8735782–8735786. doi: 10.1155/2016/8735782.
   PubMed Web of Science ®Google Scholar
• Rodrigo E, Fresnedo GF, Valero R, et al. New-onset diabetes after kidney transplantation: risk factors. J Am Soc Nephrol. 2006;17:291–295.
   PubMed Web of Science ®Google Scholar
• Burroughs TE, Swindle J, Takemoto S, et al. Diabetic complications associated with new-onset diabetes mellitus in renal transplant recipients. Transplantation. 2007;83(8):1027–1034. doi: 10.1097/01.tp.0000259617.21741.95.
   PubMed Web of Science ®Google Scholar
• Ni X Li Y, Huang T, Zhou Y, et al. Metabolic-related index to predict post-transplantation diabetes after renal transplantation. PREPRINT (Version 1) Available at Research Square. doi: 10.21203/rs.3.rs-190909/v1].
   Google Scholar
• US Renal Data System Cardiovascular Special Studies. USRDS 2003 annual data report. Chapter 9. Bethesda, MD: national Institute of Health N 2003:141–150.
   Google Scholar
• Wali RK, Wang GS, Gottlieb SS, et al. Effect of kidney transplantation on left ventricular systolic dysfunction and congestive heart failure in patients with end-stage renal disease. J Am Coll Cardiol. 2005;45(7):1051–1060. doi: 10.1016/j.jacc.2004.11.061.
   PubMed Web of Science ®Google Scholar
• Siedlecki A, Foushee M, Curtis JJ, et al. The impact of left ventricular systolic dysfunction on survival after renal transplantation. Transplantation. 2007;84(12):1610–1617. doi: 10.1097/01.tp.0000295748.42884.97.
   PubMed Web of Science ®Google Scholar
• Armstrong KA, Hiremagalur B, Haluska BA, et al. Free fatty acids are associated with obesity, insulin resistance, and atherosclerosis in renal transplant recipients. Transplantation. 2005;80(7):937–944. doi: 10.1097/01.tp.0000173792.53561.b6.
   PubMed Web of Science ®Google Scholar
• Finken MJ, Keijzer-Veen MG, Dekker FW, et al. Preterm birth and later insulin resistance: effects of birth weight and postnatal growth in a population-based longitudinal study from birth into adult life ınsulin resistance 19 years after preterm birth. Diabetologia. 2006;49(3):478–485. doi: 10.1007/s00125-005-0118-y.
   PubMed Web of Science ®Google Scholar